Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

131
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
131
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

205
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
205
Local Anesthetics: Pharmacokinetics01:13

Local Anesthetics: Pharmacokinetics

871
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
871
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

131
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
131

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the existence conditions of interaction indices in response surface models.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Physiological framework for non-invasive detection and objective nociception activity in communicative patients: a pilot case study.

Frontiers in physiology·2026
Same author

Revisiting the impulse response creates an improved PID autotuner.

Scientific reports·2025
Same author

Modeling drug retention as memory effects in obese patients using fractional and augmented models.

Scientific reports·2025
Same author

Online and personalised control of the Depth of hypnosis during induction using fractional order PID.

Journal of advanced research·2025
Same author

Artificial Intelligence-Driven Prognosis of Respiratory Mechanics: Forecasting Tissue Hysteresivity Using Long Short-Term Memory and Continuous Sensor Data.

Sensors (Basel, Switzerland)·2024

Related Experiment Video

Updated: Sep 18, 2025

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.8K

Pharmacokinetic modelling during long-term anesthesia: minimizing the gap.

Amani R Ynineb1, Erhan Yumuk2, Dana Copot3

  • 1Ghent University, Department of Electromechanics, Systems and Metal Engineering, Research Group on Dynamical Systems and Control, Technologiepark 125, Gent 9052, East-Flanders, Belgium.

Journal of Advanced Research
|June 26, 2025
PubMed
Summary

This study developed an augmented pharmacokinetic model to account for drug trapping in adipose tissue, improving anesthesia safety for obese patients. Model predictive control (MPC) reduced drug input and overdose risk during prolonged anesthesia.

Keywords:
BioimpedanceClosed-loop control of anesthesiaCole–Cole modelCompartmental modellingGeneral anesthesiaObesity

More Related Videos

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.4K
Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
03:02

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification

Published on: July 25, 2025

125

Related Experiment Videos

Last Updated: Sep 18, 2025

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.8K
Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.4K
Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
03:02

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification

Published on: July 25, 2025

125

Area of Science:

  • Pharmacology
  • Biomedical Engineering
  • Anesthesiology

Background:

  • Prolonged general anesthesia risks drug accumulation and overdose, especially in obese patients.
  • Existing pharmacokinetic (PK) models often overlook comorbidities like obesity.
  • Obesity can alter drug distribution and clearance due to adipose tissue characteristics.

Purpose of the Study:

  • To augment PK models by incorporating drug trapping in adipose tissue as a function of Body Mass Index (BMI).
  • To develop a theoretical framework linking BMI to tissue properties and delayed drug clearance.
  • To investigate the impact of obesity on drug distribution and clearance during anesthesia.

Main Methods:

  • Developed an augmented PK model with a "trap" compartment for adipose tissue.
  • Validated the model using in vitro impedance measurements and numerical simulations.
  • Employed Cole-Cole fractional-order models and genetic algorithms for parameter identification.
  • Utilized model predictive control (MPC) for closed-loop anesthesia simulations.

Main Results:

  • Fat tissue properties were confirmed to be volume-dependent.
  • Simulations showed delayed drug clearance in high-BMI patients.
  • MPC maintained anesthetic depth with reduced drug input and usage across different BMI and age groups.

Conclusions:

  • The augmented PK model effectively addresses drug trapping in obese patients.
  • MPC-based anesthesia management reduces total drug use and lowers overdose risk.
  • This approach enhances the safety and efficacy of prolonged anesthesia.